Cedars-Sinai Medical Center Cardiac Suite Singapore - English - HSA (Health Sciences Authority)

cedars-sinai medical center cardiac suite

philips electronics singapore pte ltd - general hospital - the cedars-sinai medical center (csmc) cardiac suite autoquant and qbs applications are intended to enable an automated display, review, and quantification of nuclear medicine cardiology medical images and datasets. csmc cardiac suite may be used in multiple settings including the hospital, clinic, doctors office, or remotely. the results provided should be reviewed by qualified healthcare professionals (e.g., radiologists, cardiologists, or general nuclear medicine physicians) trained in the use of medical imaging devices

CENTER-AL - ACACIA LONGIFOLIA POLLEN- acacia longifolia pollen injection, suspension
CENTER-AL - ALNUS INCANA SSP. RUGOSA POLLE United States - English - NLM (National Library of Medicine)

center-al - acacia longifolia pollen- acacia longifolia pollen injection, suspension center-al - alnus incana ssp. rugosa polle

alk-abello, inc. - acacia longifolia pollen (unii: 24so2j296o) (acacia longifolia pollen - unii:24so2j296o) - acacia longifolia pollen 10000 [pnu] in 1 ml - hyposensitization (injection) therapy is a treatment for patients exhibiting allergic reactions to seasonal pollens, dust mites, molds, animal danders, and various other inhalants, in situations where the offending allergen cannot be avoided. prior to the initiation of therapy, clinical sensitivity should be established by careful evaluation of the patient’s history confirmed by diagnostic skin testing. hyposensitization should not be prescribed for sensitivities to allergens which can be easily avoided. a patient should not be immunized against a substance which the patient has not demonstrated symptoms and/or tissue-fixed ige antibodies as demonstrated by skin testing. immunotherapy should not be attempted in patients with active asthma, severe respiratory obstruction, or cardiovascular disease. there is some evidence, although inconclusive, that routine immunizations may exacerbate autoimmune diseases. hyposensitization should be given cautiously to patients with this predisposition. the physician must w

CENTER-AL - DACTYLIS GLOMERATA POLLEN- dactylis glomerata pollen injection, suspension
CENTER-AL - CARYA ILLINOINENSIS POLLEN- United States - English - NLM (National Library of Medicine)

center-al - dactylis glomerata pollen- dactylis glomerata pollen injection, suspension center-al - carya illinoinensis pollen-

alk-abello, inc. - dactylis glomerata pollen (unii: 83n78ida7p) (dactylis glomerata pollen - unii:83n78ida7p) - dactylis glomerata pollen 20000 [pnu] in 1 ml - hyposensitization (injection) therapy is a treatment for patients exhibiting allergic reactions to seasonal pollens, dust mites, molds, animal danders, and various other inhalants, in situations where the offending allergen cannot be avoided. prior to the initiation of therapy, clinical sensitivity should be established by careful evaluation of the patient’s history confirmed by diagnostic skin testing. hyposensitization should not be prescribed for sensitivities to allergens which can be easily avoided. a patient should not be immunized against a substance which the patient has not demonstrated symptoms and/or tissue-fixed ige antibodies as demonstrated by skin testing. immunotherapy should not be attempted in patients with active asthma, severe respiratory obstruction, or cardiovascular disease. there is some evidence, although inconclusive, that routine immunizations may exacerbate autoimmune diseases. hyposensitization should be given cautiously to patients with this predisposition. the physician must w

CENTER-AL - AGROSTIS GIGANTEA- agrostis gigantea top injection, suspension
CENTER-AL - SALSOLA KALI POLLEN- salsola kali pollen United States - English - NLM (National Library of Medicine)

center-al - agrostis gigantea- agrostis gigantea top injection, suspension center-al - salsola kali pollen- salsola kali pollen

alk-abello, inc. - agrostis gigantea top (unii: a5odf78epd) (agrostis gigantea top - unii:a5odf78epd) - agrostis gigantea top 20000 [pnu] in 1 ml - hyposensitization (injection) therapy is a treatment for patients exhibiting allergic reactions to seasonal pollens, dust mites, molds, animal danders, and various other inhalants, in situations where the offending allergen cannot be avoided. prior to the initiation of therapy, clinical sensitivity should be established by careful evaluation of the patient’s history confirmed by diagnostic skin testing. hyposensitization should not be prescribed for sensitivities to allergens which can be easily avoided. a patient should not be immunized against a substance which the patient has not demonstrated symptoms and/or tissue-fixed ige antibodies as demonstrated by skin testing. immunotherapy should not be attempted in patients with active asthma, severe respiratory obstruction, or cardiovascular disease. there is some evidence, although inconclusive, that routine immunizations may exacerbate autoimmune diseases. hyposensitization should be given cautiously to patients with this predisposition. the physician must w

CENTER-AL - CHENOPODIUM ALBUM POLLEN- chenopodium album pollen injection, suspension
CENTER-AL - ACER SACCHARUM POLLEN- acer sa United States - English - NLM (National Library of Medicine)

center-al - chenopodium album pollen- chenopodium album pollen injection, suspension center-al - acer saccharum pollen- acer sa

alk-abello, inc. - chenopodium album pollen (unii: 098lkx5ncn) (chenopodium album pollen - unii:098lkx5ncn) - chenopodium album pollen 10000 [pnu] in 1 ml - hyposensitization (injection) therapy is a treatment for patients exhibiting allergic reactions to seasonal pollens, dust mites, molds, animal danders, and various other inhalants, in situations where the offending allergen cannot be avoided. prior to the initiation of therapy, clinical sensitivity should be established by careful evaluation of the patient’s history confirmed by diagnostic skin testing. hyposensitization should not be prescribed for sensitivities to allergens which can be easily avoided. a patient should not be immunized against a substance which the patient has not demonstrated symptoms and/or tissue-fixed ige antibodies as demonstrated by skin testing. immunotherapy should not be attempted in patients with active asthma, severe respiratory obstruction, or cardiovascular disease. there is some evidence, although inconclusive, that routine immunizations may exacerbate autoimmune diseases. hyposensitization should be given cautiously to patients with this predisposition. the physician must w

CENTER-AL - POPULUS DELTOIDES SSP. MONILIFERA POLLEN- populus deltoides subsp. monilifera pollen injection, suspension
CENTER-A United States - English - NLM (National Library of Medicine)

center-al - populus deltoides ssp. monilifera pollen- populus deltoides subsp. monilifera pollen injection, suspension center-a

alk-abello, inc. - populus deltoides subsp. monilifera pollen (unii: 5928lj1441) (populus deltoides subsp. monilifera pollen - unii:5928lj1441) - populus deltoides subsp. monilifera pollen 10000 [pnu] in 1 ml - hyposensitization (injection) therapy is a treatment for patients exhibiting allergic reactions to seasonal pollens, dust mites, molds, animal danders, and various other inhalants, in situations where the offending allergen cannot be avoided. prior to the initiation of therapy, clinical sensitivity should be established by careful evaluation of the patient’s history confirmed by diagnostic skin testing. hyposensitization should not be prescribed for sensitivities to allergens which can be easily avoided. a patient should not be immunized against a substance which the patient has not demonstrated symptoms and/or tissue-fixed ige antibodies as demonstrated by skin testing. immunotherapy should not be attempted in patients with active asthma, severe respiratory obstruction, or cardiovascular disease. there is some evidence, although inconclusive, that routine immunizations may exacerbate autoimmune diseases. hyposensitization should be given cautiously to patients with this predisposition. the physician must w

CENTER-AL - BROMUS INERMIS POLLEN- bromus inermis pollen injection, suspension United States - English - NLM (National Library of Medicine)

center-al - bromus inermis pollen- bromus inermis pollen injection, suspension

alk-abello, inc. - bromus inermis pollen (unii: 766qt72bk6) (bromus inermis pollen - unii:766qt72bk6) - bromus inermis pollen 10000 [pnu] in 1 ml - hyposensitization (injection) therapy is a treatment for patients exhibiting allergic reactions to seasonal pollens, dust mites, molds, animal danders, and various other inhalants, in situations where the offending allergen cannot be avoided. prior to the initiation of therapy, clinical sensitivity should be established by careful evaluation of the patient’s history confirmed by diagnostic skin testing. hyposensitization should not be prescribed for sensitivities to allergens which can be easily avoided. a patient should not be immunized against a substance which the patient has not demonstrated symptoms and/or tissue-fixed ige antibodies as demonstrated by skin testing. immunotherapy should not be attempted in patients with active asthma, severe respiratory obstruction, or cardiovascular disease. there is some evidence, although inconclusive, that routine immunizations may exacerbate autoimmune diseases. hyposensitization should be given cautiously to patients with this predisposition. the physician must w

PROCTOLAR CENTER SUPPOSITORY Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

proctolar center suppository

arab center for pharmaceuticals & chemical ind. co. - bismuth subgalate, fluocinolone acetonide, lidocaine hydrochloride - suppository - 0.1, 5, 2 %

Philips IntelliVue Information Center Singapore - English - HSA (Health Sciences Authority)

philips intellivue information center

philips electronics singapore pte ltd - general hospital - is indicated for central monitoring of multiple adult, pediatric, and neonatal patients; and where the clinician decides to monitor cardiac arrhythmia of adult, pediatric, and neonatal patients and/or st segment of adult patients to gain information for treatment, to monitor adequacy of treatment, or to exclude causes of symptoms. the philips intellivue information center is intended for use with the following bedside monitors: • intellivue patient monitors release c.0 or higher • cms revision c+ or higher, v26 and v24 revision c+ or higher • m3 (wired and wireless) release d or higher, • mrx monitor release c or higher

TEXAS MEDICAL CENTER SUPPLY- ethyl alcohol gel United States - English - NLM (National Library of Medicine)

texas medical center supply- ethyl alcohol gel

texas medical center supply llc - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antiseptic use: hand sanitizer to help decrease bacteria on skin recommended for repeated use